Browse Data and Analysis

While Colombia's regulatory environment remains friendly toward the adoption of biotech-derived commodities and other innovative technologies, Congressional anti-biotechnology initiatives continue posing a threat, risking the benefits to consumers and the agricultural sector. In 2021, genetically engineered corn area planted grew 31 percent, reaching record figures, and genetically engineered cotton area planted recovered 55 percent compared to 2020.

Despite private sector support for biotechnology, Venezuela’s ban on the domestic use of and research on modern biotechnology-derived agriculture remains in place. The backbone of this ban is the Seed Law of December 2015, which also prohibits the importation of genetically-engineered seeds.

The legal and regulatory situation to allow the planting of genetically engineered (GE) crops in Ecuador remains relatively the same as 2021. Commercial cultivation of GE crops is not permitted, however cultivation for research is allowed and an exception exists for GE products without recombinant or foreign DNA in the genome. A ruling by Ecuador’s Constitutional Court in early 2022 now makes it more difficult for the President to authorize exceptions to the GE ban.

Peru continues to enforce the extended biotechnology moratorium. In February 2021, Peru extended the previous ten-year biotechnology moratorium for another fifteen years. Similar to the previous moratorium, Peru has yet to notify the measure to the World Trade Organization. In general, biotechnology remains misunderstood by the public in Peru.

Following the approval of a GE potato variety in July 2021, the Government of Indonesia approved four GE corn events for domestic commercial cultivation in February 2022. The U.S. exported nearly $2.2 billion in GE-derived products to Indonesia in 2021.

India remains undecided on genetically engineered (GE) crops, despite its regulatory authorities clearing on the environmental release of GE eggplant and mustard events. Bt cotton (Bacillus thuringiensis) remains the sole crop derived from biotechnology (biotech) approved for commercial cultivation.

Sri Lanka does not produce genetically engineered (GE) crops or animals. There is some GE research at the laboratory level, but there is no commercialization. The lack of a legal framework and biosafety procedures are a major setback; the country is in the process of finalizing regulatory biotechnology policies.

The Government of Bulgaria (GOB) continues to oppose agricultural biotechnology and supports anti-biotech policy initiatives within the European Commission (EC). Non-governmental anti-biotech organizations, local activists, and Bulgaria’s organics industry actively spread nonscientific disinformation about biotechnology.

Korea is in the process of revising its Living Modified Organism (LMO) Act. Once completed, these revisions will define Korea’s regulatory policies for products that utilize innovative technologies, including genome editing. Finalized changes to the LMO Act are expected by the end of 2022 with implementation planned for the end of 2023.

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with the European Union’s regulations. Agricultural biotechnology is a disputed item in Ukraine. Currently, no GE events are officially approved for agricultural and food production.

This report describes the status of Burma’s production, regulations, public attitudes, trading, and labeling requirements for genetic engineered products and the current activities for agricultural biotechnology.

Ghana’s National Biosafety Authority has eventually given the green light for the environmental release and placement on the market of the pod borer resistant (PBR) or Bt. Cowpea.